Mikala Egeblad

37.1k total citations · 13 hit papers
84 papers, 19.1k citations indexed

About

Mikala Egeblad is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Mikala Egeblad has authored 84 papers receiving a total of 19.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 34 papers in Immunology and 31 papers in Molecular Biology. Recurrent topics in Mikala Egeblad's work include Immune cells in cancer (19 papers), Immunotherapy and Immune Responses (12 papers) and Cell Adhesion Molecules Research (12 papers). Mikala Egeblad is often cited by papers focused on Immune cells in cancer (19 papers), Immunotherapy and Immune Responses (12 papers) and Cell Adhesion Molecules Research (12 papers). Mikala Egeblad collaborates with scholars based in United States, Denmark and United Kingdom. Mikala Egeblad's co-authors include Zena Werb, Valerie M. Weaver, Elizabeth S. Nakasone, Morten G. Rasch, Marja Jäättelä, Amato J. Giaccia, Johnathon N. Lakins, Wolfgang Weninger, David L. Gasser and Janine T. Erler and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Mikala Egeblad

83 papers receiving 18.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New functions for the matrix metalloproteinases in cancer progression

2002 5.0k citations Mikala Egeblad, Zena Werb profile →
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling

2009 3.1k citations Kandice R. Levental, Hongmei Yu et al. Cell profile →
The entry of nanoparticles into solid tumours

2020 1.3k citations Mikala Egeblad et al. profile →
Neutrophil extracellular traps in COVID-19

2020 1.1k citations Andrew Weber, Betsy Barnes et al. JCI Insight profile →
Tumors as Organs: Complex Tissues that Interface with the Entire Organism

2010 918 citations Mikala Egeblad, Elizabeth S. Nakasone et al. profile →
Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps

2016 721 citations Miriam R. Fein, Elizabeth S. Nakasone et al. profile →
Dynamic interplay between the collagen scaffold and tumor evolution

2010 695 citations Mikala Egeblad, Morten G. Rasch et al. profile →
Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases

1998 579 citations Marja Jäättelä, Mikala Egeblad et al. profile →
Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.

2001 531 citations Terhi Kärpänen, Mikala Egeblad et al. Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) profile →
Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss

2015 468 citations John E. Wilkinson, Adrian R. Krainer et al. profile →
NETworking with cancer: The bidirectional interplay between cancer and neutrophil extracellular traps

2023 164 citations José M. Adrover, Xue‐Yan He et al. Cancer Cell profile →
Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activation

2023 148 citations Isabelle Bourget, Pascal Lopez et al. Cancer Cell profile →
Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment

2024 121 citations Xue‐Yan He, David Ng et al. Cancer Cell profile →

Peers

Countries citing papers authored by Mikala Egeblad

Since Specialization

Citations

This map shows the geographic impact of Mikala Egeblad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikala Egeblad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikala Egeblad more than expected).

Fields of papers citing papers by Mikala Egeblad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikala Egeblad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikala Egeblad. The network helps show where Mikala Egeblad may publish in the future.

Co-authorship network of co-authors of Mikala Egeblad

This figure shows the co-authorship network connecting the top 25 collaborators of Mikala Egeblad. A scholar is included among the top collaborators of Mikala Egeblad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikala Egeblad. Mikala Egeblad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Interaction between MED12 and ΔNp63 activates basal identity in pancreatic ductal adenocarcinoma 2024 ·Nature Genetics ·Diogo Maia-Silva, (unknown), (unknown), Damianos Skopelitis, (unknown), (unknown), Yuan Gao, (unknown), Xue‐Yan He, (unknown), Ledong Wan, Aktan Alpsoy, (unknown), Adrian R. Krainer, Mikala Egeblad, David L. Spector, Douglas T. Fearon, Camila O. dos Santos, Dylan J. Taatjes, Christopher R. Vakoc	6
2	Iron TAMs: The fallen protectors 2024 ·The Journal of Experimental Medicine ·Lijuan Sun, Mikala Egeblad	1
3	Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activation breakdown → 2023 ·Cancer Cell ·(unknown), (unknown), Isabelle Bourget, Pascal Lopez, (unknown), Julien Cherfils‐Vicini, Chloé Dominici, Géraldine Rios, (unknown), Bodu Liu, David L. Spector, Sidse Ehmsen, Shufang Renault, Caroline Hego, Fatima Mechta‐Grigoriou, François‐Clément Bidard, Mikkel G. Terp, Mikala Egeblad, Cédric Gaggioli, Jean Albrengues	148
4	ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activation 2023 ·Nature Cell Biology ·Yuan Gao, Xue‐Yan He, Xiaoli Wu, Yuhan Huang, (unknown), (unknown), Jonathan J. Ipsaro, Peter K. Koo, Leemor Joshua‐Tor, Kelly M. Bailey, Mikala Egeblad, Christopher R. Vakoc	19
5	OCA-T1 and OCA-T2 are coactivators of POU2F3 in the tuft cell lineage 2022 ·Nature ·Xiaoli Wu, Xue‐Yan He, Jonathan J. Ipsaro, Yuhan Huang, Jonathan Preall, David Ng, Yan Ting Shue, Julien Sage, Mikala Egeblad, Leemor Joshua‐Tor, Christopher R. Vakoc	48
6	Disulfiram inhibits neutrophil extracellular trap formation and protects rodents from acute lung injury and SARS-CoV-2 infection 2022 ·JCI Insight ·José M. Adrover, Lucía Carrau, Juliane Daßler‐Plenker, Yaron Bram, Vasuretha Chandar, Sean Houghton, David Redmond, (unknown), (unknown), Benjamin R. tenOever, Scott K. Lyons, Robert E. Schwartz, Mikala Egeblad	87
7	Isolation of mouse mammary carcinoma-derived macrophages and cancer cells for co-culture assays 2022 ·STAR Protocols ·Lijuan Sun, Xiao Han, Mikala Egeblad	6
8	Multi-color Flow Cytometry for Comprehensive Analysis of the Tumor Immune Infiltrate in a Murine Model of Breast Cancer 2021 ·BIO-PROTOCOL ·(unknown), Miriam R. Fein, Mikala Egeblad	7
9	Cancer cell CCR2 orchestrates suppression of the adaptive immune response 2020 ·The Journal of Experimental Medicine ·Miriam R. Fein, Xue‐Yan He, Ana S. Almeida, (unknown), Arnaud Pommier, Ran Yan, (unknown), Douglas T. Fearon, Linda Van Aelst, John E. Wilkinson, Camila O. dos Santos, Mikala Egeblad	45
10	Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series 2020 ·Molecular Medicine ·Andrew Weber, (unknown), Mikala Egeblad, Betsy Barnes, Tobias Janowitz	66
11	Stressing Out about Cancer Immunotherapy 2019 ·Cancer Cell ·Xue‐Yan He, David Ng, Linda Van Aelst, Mikala Egeblad	10
12	Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases 2018 ·Science ·Arnaud Pommier, Naishitha Anaparthy, (unknown), Zakiya Kelley, (unknown), Ran Yan, Cédric Auffray, Jean Albrengues, Mikala Egeblad, Christine A. Iacobuzio–Donahue, Scott K. Lyons, Douglas T. Fearon	197
13	EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth 2017 ·Journal of Hematology & Oncology ·Naiara Perurena, Carolina Zandueta, Susana Martínez-Canarias, Haritz Moreno, Silvestre Vicent, Ana S. Almeida, Elizabeth Guruceaga, Roger R. Gomis, Marta Santisteban, Mikala Egeblad, José Hermida, Fernando Lecanda	19
14	Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer 2013 ·Journal of Visualized Experiments ·Elizabeth S. Nakasone, Hanne A. Askautrud, Mikala Egeblad	12
15	Marginating Dendritic Cells of the Tumor Microenvironment Cross-Present Tumor Antigens and Stably Engage Tumor-Specific T Cells 2012 ·Cancer Cell ·John Engelhardt, Bijan Boldajipour, Peter Beemiller, (unknown), Caitlin M. Sorensen, Zena Werb, Mikala Egeblad, Matthew F. Krummel	266
16	Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to Resistance 2012 ·Cancer Cell ·Elizabeth S. Nakasone, Hanne A. Askautrud, Tim Kees, Jae‐Hyun Park, Vicki Plaks, Andrew J. Ewald, Miriam R. Fein, Morten G. Rasch, (unknown), Jing Qiu, (unknown), Pranay Sinha, Mina J. Bissell, Eirik Frengen, Zena Werb, Mikala Egeblad	381
17	Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling breakdown → 2009 ·Cell ·Kandice R. Levental, Hongmei Yu, Laura Kass, Johnathon N. Lakins, Mikala Egeblad, Janine T. Erler, Sheri F T Fong, Katalin Csiszár, Amato J. Giaccia, Wolfgang Weninger, Mitsuo Yamauchi, David L. Gasser, Valerie M. Weaver	3094
18	GATA-3 Links Tumor Differentiation and Dissemination in a Luminal Breast Cancer Model 2008 ·Cancer Cell ·Hosein Kouros‐Mehr, Seth K. Bechis, Euan M. Slorach, Laurie E. Littlepage, Mikala Egeblad, Andrew J. Ewald, Sung‐Yun Pai, I‐Cheng Ho, Zena Werb	287
19	Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. breakdown → 2001 ·Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) ·Terhi Kärpänen, Mikala Egeblad, Marika J. Karkkainen, Hajime Kubo, Seppo Ylä‐Herttuala, Marja Jäättelä, Kari Alitalo	531
20	Truncated ErbB2 receptor enhances ErbB1 signaling and induces reversible, ERK-independent loss of epithelial morphology 2001 ·International Journal of Cancer ·Mikala Egeblad, Ole Hartvig Mortensen, (unknown)	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact